H Schrezenmeier1, S Körper1, B Höchsmann1. Show Affiliations » 1. Institut für Klinische Transfusionsmedizin und Immungenetik Ulm.
Abstract
Entities: Disease
Mesh： See more » Anemia, Aplastic/diagnosisAnemia, Aplastic/geneticsAnemia, Aplastic/therapyAntilymphocyte Serum/therapeutic useBenzoates/therapeutic useDNA Mutational AnalysisDrug Therapy, CombinationEarly Medical InterventionHematopoietic Stem Cell TransplantationHemoglobinuria, Paroxysmal/diagnosisHemoglobinuria, Paroxysmal/geneticsHemoglobinuria, Paroxysmal/therapyHumansHydrazines/therapeutic useImmunosuppressive Agents/therapeutic useMyelodysplastic Syndromes/diagnosisMyelodysplastic Syndromes/geneticsMyelodysplastic Syndromes/therapyPrognosisPyrazoles/therapeutic useRandomized Controlled Trials as TopicTelomerase/geneticsTelomere-Binding Proteins/geneticsTransplantation Conditioning
Substances： See more » Antilymphocyte SerumBenzoatesHydrazinesImmunosuppressive AgentsPyrazolesTelomere-Binding Proteinsshelterin, humanTelomeraseeltrombopag
Year: 2014 PMID： 25423456 DOI： 10.1055/s-0034-1387407
Source DB: PubMed Journal: Dtsch Med Wochenschr ISSN： 0012-0472 Impact factor: 0.628